<!DOCTYPE html >
<html lang="en">
<head>
    <meta charset="UTF-8">
    <link rel="stylesheet" type="text/css" href='https://code.jquery.com/ui/1.11.4/themes/smoothness/jquery-ui.css'/>
    <link rel="stylesheet"
          href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
    <link rel="stylesheet"
          href="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/4.0.0-alpha.6/css/bootstrap.min.css"/>
    <style>
        .link_continuous {
            fill: none;
            stroke-width: 1px;
        }

        .link_dashed {
            fill: none;
            stroke-width: 1px;
            stroke-dasharray: 4, 4;

        }

        .Pathology {
            fill: #FF7F0E;
        }

        .Abundance {
            fill: #AEC7E8;
        }

        .Gene {
            fill: #FFBB78;
        }

        .miRNA {
            fill: #D62728;
        }

        .Protein {
            fill: #1F77B4;
        }

        .RNA {
            fill: #FF9896;
        }

        .BiologicalProcess {
            fill: #2CA02C;
        }

        .Pathology {
            fill: #FF7F0E;
        }

        .Complex {
            fill: #98DF8A;
        }

        .Composite {
            fill: #9467BD;
        }

    </style>
    <script type="text/javascript">
        window.graph = {"directed": true, "multigraph": true, "graph": {"pybel_version": "0.4.1", "name": "Alzheimer's Disease Model - Subgraph - GABA subgraph", "annotation_list": {}}, "nodes": [{"function": "Protein", "namespace": "HGNC", "name": "APP", "id": ["Protein", "HGNC", "APP"]}, {"function": "Protein", "namespace": "HGNC", "name": "GRIN2B", "variants": [{"kind": "pmod", "identifier": {"namespace": "bel", "name": "Ph"}}], "id": ["Protein", "HGNC", "GRIN2B", ["pmod", ["bel", "Ph"]]]}, {"function": "Protein", "namespace": "HGNC", "name": "APP", "variants": [{"kind": "frag", "start": 672, "stop": 713}], "id": ["Protein", "HGNC", "APP", ["frag", [672, 713]]]}, {"function": "Protein", "namespace": "HGNC", "name": "EGR1", "id": ["Protein", "HGNC", "EGR1"]}, {"function": "Pathology", "namespace": "MESHD", "name": "Alzheimer Disease", "id": ["Pathology", "MESHD", "Alzheimer Disease"]}, {"function": "BiologicalProcess", "namespace": "GOBP", "name": "synaptic transmission, cholinergic", "id": ["BiologicalProcess", "GOBP", "synaptic transmission, cholinergic"]}, {"function": "Protein", "namespace": "HGNC", "name": "PSEN2", "id": ["Protein", "HGNC", "PSEN2"]}, {"function": "Protein", "namespace": "HGNC", "name": "TNF", "id": ["Protein", "HGNC", "TNF"]}, {"function": "Protein", "namespace": "HGNC", "name": "GABRA1", "id": ["Protein", "HGNC", "GABRA1"]}, {"function": "Protein", "namespace": "HGNC", "name": "GABRA2", "id": ["Protein", "HGNC", "GABRA2"]}, {"function": "Protein", "namespace": "HGNC", "name": "GABRA3", "id": ["Protein", "HGNC", "GABRA3"]}, {"function": "Protein", "namespace": "HGNC", "name": "GABRA4", "id": ["Protein", "HGNC", "GABRA4"]}, {"function": "Protein", "namespace": "HGNC", "name": "GABRA5", "id": ["Protein", "HGNC", "GABRA5"]}, {"function": "Protein", "namespace": "HGNC", "name": "GABRA6", "id": ["Protein", "HGNC", "GABRA6"]}, {"function": "Protein", "namespace": "HGNC", "name": "GABRB1", "id": ["Protein", "HGNC", "GABRB1"]}, {"function": "Protein", "namespace": "HGNC", "name": "GABRB2", "id": ["Protein", "HGNC", "GABRB2"]}, {"function": "Protein", "namespace": "HGNC", "name": "GABRB3", "id": ["Protein", "HGNC", "GABRB3"]}, {"function": "Protein", "namespace": "HGNC", "name": "GABRG1", "id": ["Protein", "HGNC", "GABRG1"]}, {"function": "Protein", "namespace": "HGNC", "name": "GABRG2", "id": ["Protein", "HGNC", "GABRG2"]}, {"function": "Protein", "namespace": "HGNC", "name": "GABRG3", "id": ["Protein", "HGNC", "GABRG3"]}, {"function": "Protein", "namespace": "HGNC", "name": "GABRD", "id": ["Protein", "HGNC", "GABRD"]}, {"function": "Protein", "namespace": "HGNC", "name": "GABRE", "id": ["Protein", "HGNC", "GABRE"]}, {"function": "Protein", "namespace": "HGNC", "name": "GABRP", "id": ["Protein", "HGNC", "GABRP"]}, {"function": "Protein", "namespace": "HGNC", "name": "GABRQ", "id": ["Protein", "HGNC", "GABRQ"]}, {"function": "Protein", "namespace": "HGNC", "name": "GABBR1", "id": ["Protein", "HGNC", "GABBR1"]}, {"function": "BiologicalProcess", "namespace": "GOBP", "name": "regulation of N-methyl-D-aspartate selective glutamate receptor activity", "id": ["BiologicalProcess", "GOBP", "regulation of N-methyl-D-aspartate selective glutamate receptor activity"]}, {"function": "BiologicalProcess", "namespace": "GOBP", "name": "regulation of synaptic plasticity", "id": ["BiologicalProcess", "GOBP", "regulation of synaptic plasticity"]}, {"function": "Protein", "namespace": "HGNC", "name": "GRIN2B", "id": ["Protein", "HGNC", "GRIN2B"]}, {"function": "BiologicalProcess", "namespace": "GOBP", "name": "cognition", "id": ["BiologicalProcess", "GOBP", "cognition"]}, {"function": "BiologicalProcess", "namespace": "GOBP", "name": "learning", "id": ["BiologicalProcess", "GOBP", "learning"]}, {"function": "BiologicalProcess", "namespace": "GOBP", "name": "memory", "id": ["BiologicalProcess", "GOBP", "memory"]}, {"function": "Protein", "namespace": "HGNC", "name": "CHRNA4", "id": ["Protein", "HGNC", "CHRNA4"]}, {"function": "Abundance", "namespace": "CHEBI", "name": "gamma-aminobutyric acid", "id": ["Abundance", "CHEBI", "gamma-aminobutyric acid"]}, {"function": "Abundance", "namespace": "CHEBI", "name": "glutamate(1-)", "id": ["Abundance", "CHEBI", "glutamate(1-)"]}, {"function": "Protein", "namespace": "HGNC", "name": "CHRNB2", "id": ["Protein", "HGNC", "CHRNB2"]}, {"function": "BiologicalProcess", "namespace": "GOBP", "name": "regulation of neuronal synaptic plasticity", "id": ["BiologicalProcess", "GOBP", "regulation of neuronal synaptic plasticity"]}, {"function": "Protein", "namespace": "HGNC", "name": "CHRNA2", "id": ["Protein", "HGNC", "CHRNA2"]}, {"function": "Protein", "namespace": "HGNC", "name": "CHRNA3", "id": ["Protein", "HGNC", "CHRNA3"]}, {"function": "Protein", "namespace": "HGNC", "name": "CHRNA5", "id": ["Protein", "HGNC", "CHRNA5"]}, {"function": "Protein", "namespace": "HGNC", "name": "CHRNA6", "id": ["Protein", "HGNC", "CHRNA6"]}, {"function": "Protein", "namespace": "HGNC", "name": "CHRNA7", "id": ["Protein", "HGNC", "CHRNA7"]}, {"function": "Protein", "namespace": "HGNC", "name": "CHRNA9", "id": ["Protein", "HGNC", "CHRNA9"]}, {"function": "Protein", "namespace": "HGNC", "name": "CHRNA10", "id": ["Protein", "HGNC", "CHRNA10"]}, {"function": "Protein", "namespace": "HGNC", "name": "CHRNB3", "id": ["Protein", "HGNC", "CHRNB3"]}, {"function": "Protein", "namespace": "HGNC", "name": "CHRNB4", "id": ["Protein", "HGNC", "CHRNB4"]}, {"function": "Abundance", "namespace": "CHEBI", "name": "galanthamine", "id": ["Abundance", "CHEBI", "galanthamine"]}, {"function": "Abundance", "namespace": "CHEBI", "name": "1-(3-chlorophenyl)piperazine", "id": ["Abundance", "CHEBI", "1-(3-chlorophenyl)piperazine"]}, {"function": "Protein", "namespace": "HGNC", "name": "GABBR2", "id": ["Protein", "HGNC", "GABBR2"]}, {"function": "BiologicalProcess", "namespace": "GOBP", "name": "cAMP catabolic process", "id": ["BiologicalProcess", "GOBP", "cAMP catabolic process"]}, {"function": "Abundance", "namespace": "CHEMBL", "name": "Nefiracetam", "id": ["Abundance", "CHEMBL", "Nefiracetam"]}, {"function": "Protein", "namespace": "HGNC", "name": "PRKCA", "id": ["Protein", "HGNC", "PRKCA"]}, {"function": "BiologicalProcess", "namespace": "GOBP", "name": "protein kinase A signaling", "id": ["BiologicalProcess", "GOBP", "protein kinase A signaling"]}, {"function": "Abundance", "namespace": "CHEBI", "name": "EC 3.1.1.7 (acetylcholinesterase) inhibitor", "id": ["Abundance", "CHEBI", "EC 3.1.1.7 (acetylcholinesterase) inhibitor"]}, {"function": "BiologicalProcess", "namespace": "GOBP", "name": "long-term synaptic potentiation", "id": ["BiologicalProcess", "GOBP", "long-term synaptic potentiation"]}, {"function": "Complex", "namespace": "SCOMP", "name": "CAMK2 Complex", "id": ["Complex", "SCOMP", "CAMK2 Complex"]}, {"function": "Complex", "id": ["Complex", ["Abundance", "CHEMBL", "Nefiracetam"], ["Protein", "HGNC", "PRKCA"]]}, {"function": "Protein", "namespace": "HGNC", "name": "GRIA1", "variants": [{"kind": "pmod", "identifier": {"namespace": "bel", "name": "Ph"}, "code": "Ser", "pos": 831}], "id": ["Protein", "HGNC", "GRIA1", ["pmod", ["bel", "Ph"], "Ser", 831]]}, {"function": "Protein", "namespace": "HGNC", "name": "GPHN", "id": ["Protein", "HGNC", "GPHN"]}, {"function": "Pathology", "namespace": "MESHD", "name": "Glaucoma", "id": ["Pathology", "MESHD", "Glaucoma"]}, {"function": "Abundance", "namespace": "SCHEM", "name": "Glatiramer acetate", "id": ["Abundance", "SCHEM", "Glatiramer acetate"]}, {"function": "Complex", "id": ["Complex", ["Protein", "HGNC", "EGR1"], ["Protein", "HGNC", "PSEN2"]]}, {"function": "Abundance", "namespace": "CHEBI", "name": "copper sulphate(5.H2O)", "id": ["Abundance", "CHEBI", "copper sulphate(5.H2O)"]}, {"function": "RNA", "namespace": "HGNC", "name": "GABRA5", "id": ["RNA", "HGNC", "GABRA5"]}, {"function": "RNA", "namespace": "HGNC", "name": "GABRB3", "id": ["RNA", "HGNC", "GABRB3"]}, {"function": "Abundance", "namespace": "CHEBI", "name": "estradiol", "id": ["Abundance", "CHEBI", "estradiol"]}, {"function": "RNA", "namespace": "HGNC", "name": "GABRA4", "id": ["RNA", "HGNC", "GABRA4"]}, {"function": "RNA", "namespace": "HGNC", "name": "GABRA3", "id": ["RNA", "HGNC", "GABRA3"]}], "links": [{"relation": "increases", "evidence": "In immunoblotting analysis, nefiracetam treatment increased the PKCalpha activity with a bell-shaped dose-response relationship peaking at 10 nM, thereby increasing phosphorylation of PKC substrate and NMDA receptor. Nefiracetam treatment did not affect the PKA activity.", "citation": {"type": "PubMed", "name": "Mol Pharmacol. 2007 Feb;71(2):580-7", "reference": "17095583"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 0, "target": 1, "key": 0}, {"relation": "negativeCorrelation", "evidence": "Further, EGR1 levels were negatively correlated with hippocampal amyloid-β plaque burden.This study presents global gene expression profiles associated with GA immunization in a glaucoma rat model.", "citation": {"type": "PubMed", "name": "Invest Ophthalmol Vis Sci. 2011 Nov 21;52(12):9033-46", "reference": "21969301"}, "annotations": {"Species": "10116", "MeSHDisease": "Glaucoma", "NervousSystem": "Hippocampus", "Subgraph": "GABA subgraph"}, "source": 2, "target": 3, "key": 0}, {"relation": "association", "evidence": "In AD-Tg mice, a significant increase in hippocampal EGR1 protein levels was also found in response to GA immunization.", "citation": {"type": "PubMed", "name": "Invest Ophthalmol Vis Sci. 2011 Nov 21;52(12):9033-46", "reference": "21969301"}, "annotations": {"MeSHDisease": "Alzheimer Disease", "NervousSystem": "Hippocampus", "Species": "10090", "Subgraph": "GABA subgraph"}, "source": 3, "target": 4, "key": 1}, {"relation": "association", "evidence": "Egr-1 upregulates the Alzheimer's disease presenilin-2 gene in neuronal cells.", "citation": {"type": "PubMed", "name": "Gene. 2003 Oct 30;318:113-24", "reference": "14585504"}, "annotations": {"MeSHDisease": "Alzheimer Disease", "Subgraph": "GABA subgraph"}, "source": 3, "target": 4, "key": 2}, {"relation": "association", "evidence": "Most forms of neuronal plasticity are associated with the induction of the transcription factor zif268 (egr1).", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 3, "target": 35, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 3, "target": 8, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 3, "target": 9, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 3, "target": 10, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 3, "target": 11, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 3, "target": 12, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 3, "target": 13, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 3, "target": 14, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 3, "target": 15, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 3, "target": 16, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 3, "target": 17, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 3, "target": 18, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 3, "target": 19, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 3, "target": 20, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 3, "target": 21, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 3, "target": 22, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 3, "target": 23, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 3, "target": 25, "key": 0}, {"relation": "association", "evidence": "In addition, zif268 alters the transcription of genes associated with GABA(A)R expression and trafficking, such as ubiquilin and gephyrin.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 3, "target": 57, "key": 0}, {"relation": "negativeCorrelation", "evidence": "Further, EGR1 levels were negatively correlated with hippocampal amyloid-β plaque burden.This study presents global gene expression profiles associated with GA immunization in a glaucoma rat model.", "citation": {"type": "PubMed", "name": "Invest Ophthalmol Vis Sci. 2011 Nov 21;52(12):9033-46", "reference": "21969301"}, "annotations": {"Species": "10116", "MeSHDisease": "Glaucoma", "NervousSystem": "Hippocampus", "Subgraph": "GABA subgraph"}, "source": 3, "target": 2, "key": 0}, {"relation": "association", "evidence": "Further, EGR1 levels were negatively correlated with hippocampal amyloid-β plaque burden.This study presents global gene expression profiles associated with GA immunization in a glaucoma rat model.", "citation": {"type": "PubMed", "name": "Invest Ophthalmol Vis Sci. 2011 Nov 21;52(12):9033-46", "reference": "21969301"}, "annotations": {"Species": "10116", "MeSHDisease": "Glaucoma", "NervousSystem": "Hippocampus", "Subgraph": "GABA subgraph"}, "source": 3, "target": 58, "key": 0}, {"relation": "increases", "evidence": "Moreover, it identifies EGR1 transcription factor as a potential mediator for GA-induced neuroprotection in both glaucoma and AD.", "citation": {"type": "PubMed", "name": "Invest Ophthalmol Vis Sci. 2011 Nov 21;52(12):9033-46", "reference": "21969301"}, "annotations": {"Subgraph": "GABA subgraph", "MeSHDisease": "Glaucoma"}, "source": 3, "target": 59, "key": 0}, {"relation": "increases", "evidence": "Moreover, it identifies EGR1 transcription factor as a potential mediator for GA-induced neuroprotection in both glaucoma and AD.", "citation": {"type": "PubMed", "name": "Invest Ophthalmol Vis Sci. 2011 Nov 21;52(12):9033-46", "reference": "21969301"}, "annotations": {"Subgraph": "GABA subgraph", "MeSHDisease": "Alzheimer Disease"}, "source": 3, "target": 59, "key": 1}, {"relation": "increases", "evidence": "Egr-1 upregulates the Alzheimer's disease presenilin-2 gene in neuronal cells.", "citation": {"type": "PubMed", "name": "Gene. 2003 Oct 30;318:113-24", "reference": "14585504"}, "annotations": {"MeSHDisease": "Alzheimer Disease", "Subgraph": "GABA subgraph"}, "source": 3, "target": 6, "key": 0}, {"relation": "decreases", "evidence": "The nefiracetam-induced increase in the frequency of mEPSCs and mIPSCs over and above the level achieved by ACh alone would contribute to the therapeutic effect of nefiracetam as the cholinergic system is known to be downregulated in the brain of Alzheimer's disease patients.The therapeutic effects of galantamine are ascribed to the modest potentiation of nACh receptor and NMDA receptor activities in addition to the modest inhibition of acetylcholinesterase.", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 4, "target": 5, "key": 2}, {"relation": "association", "evidence": "In AD-Tg mice, a significant increase in hippocampal EGR1 protein levels was also found in response to GA immunization.", "citation": {"type": "PubMed", "name": "Invest Ophthalmol Vis Sci. 2011 Nov 21;52(12):9033-46", "reference": "21969301"}, "annotations": {"MeSHDisease": "Alzheimer Disease", "NervousSystem": "Hippocampus", "Species": "10090", "Subgraph": "GABA subgraph"}, "source": 4, "target": 3, "key": 1}, {"relation": "association", "evidence": "Egr-1 upregulates the Alzheimer's disease presenilin-2 gene in neuronal cells.", "citation": {"type": "PubMed", "name": "Gene. 2003 Oct 30;318:113-24", "reference": "14585504"}, "annotations": {"MeSHDisease": "Alzheimer Disease", "Subgraph": "GABA subgraph"}, "source": 4, "target": 3, "key": 2}, {"relation": "association", "evidence": "Egr-1 upregulates the Alzheimer's disease presenilin-2 gene in neuronal cells.", "citation": {"type": "PubMed", "name": "Gene. 2003 Oct 30;318:113-24", "reference": "14585504"}, "annotations": {"MeSHDisease": "Alzheimer Disease", "Subgraph": "GABA subgraph"}, "source": 4, "target": 6, "key": 0}, {"relation": "association", "evidence": "Egr-1 upregulates the Alzheimer's disease presenilin-2 gene in neuronal cells.", "citation": {"type": "PubMed", "name": "Gene. 2003 Oct 30;318:113-24", "reference": "14585504"}, "annotations": {"MeSHDisease": "Alzheimer Disease", "Subgraph": "GABA subgraph"}, "source": 6, "target": 4, "key": 0}, {"relation": "decreases", "evidence": "In addition, TNF- Î± can potentiate glutamate-mediated cytotoxicity by two complementary mechanisms: indirectly, by inhibiting glutamate transport on astrocytes, and directly, by rapidly triggering the surface expression of Ca+2 permeable-AMPA receptors and NMDA receptors, while decreasing inhibitory GABAA receptors on neurons.", "citation": {"type": "PubMed", "name": "Mediators Inflamm. 2014;2014:861231", "reference": "24966471"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 7, "target": 8, "key": 0}, {"relation": "decreases", "evidence": "In addition, TNF- Î± can potentiate glutamate-mediated cytotoxicity by two complementary mechanisms: indirectly, by inhibiting glutamate transport on astrocytes, and directly, by rapidly triggering the surface expression of Ca+2 permeable-AMPA receptors and NMDA receptors, while decreasing inhibitory GABAA receptors on neurons.", "citation": {"type": "PubMed", "name": "Mediators Inflamm. 2014;2014:861231", "reference": "24966471"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 7, "target": 9, "key": 0}, {"relation": "decreases", "evidence": "In addition, TNF- Î± can potentiate glutamate-mediated cytotoxicity by two complementary mechanisms: indirectly, by inhibiting glutamate transport on astrocytes, and directly, by rapidly triggering the surface expression of Ca+2 permeable-AMPA receptors and NMDA receptors, while decreasing inhibitory GABAA receptors on neurons.", "citation": {"type": "PubMed", "name": "Mediators Inflamm. 2014;2014:861231", "reference": "24966471"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 7, "target": 10, "key": 0}, {"relation": "decreases", "evidence": "In addition, TNF- Î± can potentiate glutamate-mediated cytotoxicity by two complementary mechanisms: indirectly, by inhibiting glutamate transport on astrocytes, and directly, by rapidly triggering the surface expression of Ca+2 permeable-AMPA receptors and NMDA receptors, while decreasing inhibitory GABAA receptors on neurons.", "citation": {"type": "PubMed", "name": "Mediators Inflamm. 2014;2014:861231", "reference": "24966471"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 7, "target": 11, "key": 0}, {"relation": "decreases", "evidence": "In addition, TNF- Î± can potentiate glutamate-mediated cytotoxicity by two complementary mechanisms: indirectly, by inhibiting glutamate transport on astrocytes, and directly, by rapidly triggering the surface expression of Ca+2 permeable-AMPA receptors and NMDA receptors, while decreasing inhibitory GABAA receptors on neurons.", "citation": {"type": "PubMed", "name": "Mediators Inflamm. 2014;2014:861231", "reference": "24966471"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 7, "target": 12, "key": 0}, {"relation": "decreases", "evidence": "In addition, TNF- Î± can potentiate glutamate-mediated cytotoxicity by two complementary mechanisms: indirectly, by inhibiting glutamate transport on astrocytes, and directly, by rapidly triggering the surface expression of Ca+2 permeable-AMPA receptors and NMDA receptors, while decreasing inhibitory GABAA receptors on neurons.", "citation": {"type": "PubMed", "name": "Mediators Inflamm. 2014;2014:861231", "reference": "24966471"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 7, "target": 13, "key": 0}, {"relation": "decreases", "evidence": "In addition, TNF- Î± can potentiate glutamate-mediated cytotoxicity by two complementary mechanisms: indirectly, by inhibiting glutamate transport on astrocytes, and directly, by rapidly triggering the surface expression of Ca+2 permeable-AMPA receptors and NMDA receptors, while decreasing inhibitory GABAA receptors on neurons.", "citation": {"type": "PubMed", "name": "Mediators Inflamm. 2014;2014:861231", "reference": "24966471"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 7, "target": 14, "key": 0}, {"relation": "decreases", "evidence": "In addition, TNF- Î± can potentiate glutamate-mediated cytotoxicity by two complementary mechanisms: indirectly, by inhibiting glutamate transport on astrocytes, and directly, by rapidly triggering the surface expression of Ca+2 permeable-AMPA receptors and NMDA receptors, while decreasing inhibitory GABAA receptors on neurons.", "citation": {"type": "PubMed", "name": "Mediators Inflamm. 2014;2014:861231", "reference": "24966471"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 7, "target": 15, "key": 0}, {"relation": "decreases", "evidence": "In addition, TNF- Î± can potentiate glutamate-mediated cytotoxicity by two complementary mechanisms: indirectly, by inhibiting glutamate transport on astrocytes, and directly, by rapidly triggering the surface expression of Ca+2 permeable-AMPA receptors and NMDA receptors, while decreasing inhibitory GABAA receptors on neurons.", "citation": {"type": "PubMed", "name": "Mediators Inflamm. 2014;2014:861231", "reference": "24966471"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 7, "target": 16, "key": 0}, {"relation": "decreases", "evidence": "In addition, TNF- Î± can potentiate glutamate-mediated cytotoxicity by two complementary mechanisms: indirectly, by inhibiting glutamate transport on astrocytes, and directly, by rapidly triggering the surface expression of Ca+2 permeable-AMPA receptors and NMDA receptors, while decreasing inhibitory GABAA receptors on neurons.", "citation": {"type": "PubMed", "name": "Mediators Inflamm. 2014;2014:861231", "reference": "24966471"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 7, "target": 17, "key": 0}, {"relation": "decreases", "evidence": "In addition, TNF- Î± can potentiate glutamate-mediated cytotoxicity by two complementary mechanisms: indirectly, by inhibiting glutamate transport on astrocytes, and directly, by rapidly triggering the surface expression of Ca+2 permeable-AMPA receptors and NMDA receptors, while decreasing inhibitory GABAA receptors on neurons.", "citation": {"type": "PubMed", "name": "Mediators Inflamm. 2014;2014:861231", "reference": "24966471"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 7, "target": 18, "key": 0}, {"relation": "decreases", "evidence": "In addition, TNF- Î± can potentiate glutamate-mediated cytotoxicity by two complementary mechanisms: indirectly, by inhibiting glutamate transport on astrocytes, and directly, by rapidly triggering the surface expression of Ca+2 permeable-AMPA receptors and NMDA receptors, while decreasing inhibitory GABAA receptors on neurons.", "citation": {"type": "PubMed", "name": "Mediators Inflamm. 2014;2014:861231", "reference": "24966471"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 7, "target": 19, "key": 0}, {"relation": "decreases", "evidence": "In addition, TNF- Î± can potentiate glutamate-mediated cytotoxicity by two complementary mechanisms: indirectly, by inhibiting glutamate transport on astrocytes, and directly, by rapidly triggering the surface expression of Ca+2 permeable-AMPA receptors and NMDA receptors, while decreasing inhibitory GABAA receptors on neurons.", "citation": {"type": "PubMed", "name": "Mediators Inflamm. 2014;2014:861231", "reference": "24966471"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 7, "target": 20, "key": 0}, {"relation": "decreases", "evidence": "In addition, TNF- Î± can potentiate glutamate-mediated cytotoxicity by two complementary mechanisms: indirectly, by inhibiting glutamate transport on astrocytes, and directly, by rapidly triggering the surface expression of Ca+2 permeable-AMPA receptors and NMDA receptors, while decreasing inhibitory GABAA receptors on neurons.", "citation": {"type": "PubMed", "name": "Mediators Inflamm. 2014;2014:861231", "reference": "24966471"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 7, "target": 21, "key": 0}, {"relation": "decreases", "evidence": "In addition, TNF- Î± can potentiate glutamate-mediated cytotoxicity by two complementary mechanisms: indirectly, by inhibiting glutamate transport on astrocytes, and directly, by rapidly triggering the surface expression of Ca+2 permeable-AMPA receptors and NMDA receptors, while decreasing inhibitory GABAA receptors on neurons.", "citation": {"type": "PubMed", "name": "Mediators Inflamm. 2014;2014:861231", "reference": "24966471"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 7, "target": 22, "key": 0}, {"relation": "decreases", "evidence": "In addition, TNF- Î± can potentiate glutamate-mediated cytotoxicity by two complementary mechanisms: indirectly, by inhibiting glutamate transport on astrocytes, and directly, by rapidly triggering the surface expression of Ca+2 permeable-AMPA receptors and NMDA receptors, while decreasing inhibitory GABAA receptors on neurons.", "citation": {"type": "PubMed", "name": "Mediators Inflamm. 2014;2014:861231", "reference": "24966471"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 7, "target": 23, "key": 0}, {"relation": "decreases", "evidence": "In addition, TNF- Î± can potentiate glutamate-mediated cytotoxicity by two complementary mechanisms: indirectly, by inhibiting glutamate transport on astrocytes, and directly, by rapidly triggering the surface expression of Ca+2 permeable-AMPA receptors and NMDA receptors, while decreasing inhibitory GABAA receptors on neurons.", "citation": {"type": "PubMed", "name": "Mediators Inflamm. 2014;2014:861231", "reference": "24966471"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 7, "target": 24, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 8, "target": 26, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 8, "target": 3, "key": 0}, {"relation": "association", "evidence": "1-(3-chlorophenyl)piperazine affects the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein co-treated with GABBR2 protein co-treated with GABRG2 protein]]", "citation": {"type": "PubMed", "name": "Reference from AD_HBP Data", "reference": "21729720"}, "annotations": {"Species": "9606", "Subgraph": "GABA subgraph"}, "source": 8, "target": 46, "key": 0}, {"relation": "association", "evidence": "1-(3-chlorophenyl)piperazine affects the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein co-treated with GABBR2 protein co-treated with GABRG2 protein]]", "citation": {"type": "PubMed", "name": "Reference from AD_HBP Data", "reference": "21729720"}, "annotations": {"Species": "9606", "Subgraph": "GABA subgraph"}, "source": 8, "target": 46, "key": 1}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 9, "target": 26, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 9, "target": 3, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 10, "target": 26, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 10, "target": 3, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 11, "target": 26, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 11, "target": 3, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 12, "target": 26, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 12, "target": 3, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 13, "target": 26, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 13, "target": 3, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 14, "target": 26, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 14, "target": 3, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 15, "target": 26, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 15, "target": 3, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 16, "target": 26, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 16, "target": 3, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 17, "target": 26, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 17, "target": 3, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 18, "target": 26, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 18, "target": 3, "key": 0}, {"relation": "association", "evidence": "1-(3-chlorophenyl)piperazine affects the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein co-treated with GABBR2 protein co-treated with GABRG2 protein]]", "citation": {"type": "PubMed", "name": "Reference from AD_HBP Data", "reference": "21729720"}, "annotations": {"Species": "9606", "Subgraph": "GABA subgraph"}, "source": 18, "target": 46, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 19, "target": 26, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 19, "target": 3, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 20, "target": 26, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 20, "target": 3, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 21, "target": 26, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 21, "target": 3, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 22, "target": 26, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 22, "target": 3, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 23, "target": 26, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 23, "target": 3, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 25, "target": 26, "key": 0}, {"relation": "association", "evidence": "Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 25, "target": 3, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 26, "target": 8, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 26, "target": 9, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 26, "target": 10, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 26, "target": 11, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 26, "target": 12, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 26, "target": 13, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 26, "target": 14, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 26, "target": 15, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 26, "target": 16, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 26, "target": 17, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 26, "target": 18, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 26, "target": 19, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 26, "target": 20, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 26, "target": 21, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 26, "target": 22, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 26, "target": 23, "key": 0}, {"relation": "association", "evidence": "The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 26, "target": 25, "key": 0}, {"relation": "increases", "evidence": "In conclusion, nefiracetam enhances NMDA-receptor function through stimulation of its glycine binding site and nefiracetam-induced CaMKII activation likely contributes to improvement of cognition, learning, and memory.", "citation": {"type": "PubMed", "name": "J Pharmacol Sci. 2011;117(1):6-11", "reference": "21821968"}, "annotations": {"Species": "10116", "Subgraph": "GABA subgraph"}, "source": 27, "target": 28, "key": 0}, {"relation": "increases", "evidence": "In conclusion, nefiracetam enhances NMDA-receptor function through stimulation of its glycine binding site and nefiracetam-induced CaMKII activation likely contributes to improvement of cognition, learning, and memory.", "citation": {"type": "PubMed", "name": "J Pharmacol Sci. 2011;117(1):6-11", "reference": "21821968"}, "annotations": {"Species": "10116", "Subgraph": "GABA subgraph"}, "source": 27, "target": 29, "key": 0}, {"relation": "increases", "evidence": "In conclusion, nefiracetam enhances NMDA-receptor function through stimulation of its glycine binding site and nefiracetam-induced CaMKII activation likely contributes to improvement of cognition, learning, and memory.", "citation": {"type": "PubMed", "name": "J Pharmacol Sci. 2011;117(1):6-11", "reference": "21821968"}, "annotations": {"Species": "10116", "Subgraph": "GABA subgraph"}, "source": 27, "target": 30, "key": 0}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "subject": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 31, "target": 32, "key": 0}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "subject": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 31, "target": 33, "key": 0}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "subject": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 34, "target": 33, "key": 0}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "subject": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 34, "target": 33, "key": 2}, {"relation": "association", "evidence": "Most forms of neuronal plasticity are associated with the induction of the transcription factor zif268 (egr1).", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 35, "target": 3, "key": 0}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "subject": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 36, "target": 32, "key": 0}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "subject": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 36, "target": 33, "key": 0}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "subject": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 37, "target": 32, "key": 0}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "subject": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 37, "target": 33, "key": 0}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "subject": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 38, "target": 32, "key": 0}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "subject": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 38, "target": 33, "key": 0}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "subject": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 39, "target": 32, "key": 0}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "subject": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 39, "target": 33, "key": 0}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "subject": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 40, "target": 32, "key": 0}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "subject": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 40, "target": 33, "key": 0}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "subject": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 41, "target": 32, "key": 0}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "subject": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 41, "target": 33, "key": 0}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "subject": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 42, "target": 32, "key": 0}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "subject": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 42, "target": 33, "key": 0}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "subject": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 43, "target": 33, "key": 0}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "subject": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 43, "target": 33, "key": 2}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "subject": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 44, "target": 33, "key": 0}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "subject": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 44, "target": 33, "key": 2}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "object": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 45, "target": 36, "key": 1}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "object": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 45, "target": 37, "key": 1}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "object": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 45, "target": 31, "key": 1}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "object": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 45, "target": 38, "key": 1}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "object": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 45, "target": 39, "key": 1}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "object": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 45, "target": 40, "key": 1}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "object": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 45, "target": 41, "key": 1}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "object": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 45, "target": 42, "key": 1}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "object": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 45, "target": 34, "key": 1}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "object": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 45, "target": 43, "key": 1}, {"relation": "increases", "evidence": "Galantamine and nefiracetam have been shown to potentiate the phasic activity of nicotinic acetylcholine receptors (nAChRss) in the brain. Stimulation of nAChRss is also known to cause release of various neurotransmitters including glutamate and gamma-aminobutyric acid (GABA).", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "object": {"modifier": "Activity"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 45, "target": 44, "key": 1}, {"relation": "association", "evidence": "1-(3-chlorophenyl)piperazine affects the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein co-treated with GABBR2 protein co-treated with GABRG2 protein]]", "citation": {"type": "PubMed", "name": "Reference from AD_HBP Data", "reference": "21729720"}, "annotations": {"Species": "9606", "Subgraph": "GABA subgraph"}, "source": 46, "target": 8, "key": 0}, {"relation": "association", "evidence": "1-(3-chlorophenyl)piperazine affects the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein co-treated with GABBR2 protein co-treated with GABRG2 protein]]", "citation": {"type": "PubMed", "name": "Reference from AD_HBP Data", "reference": "21729720"}, "annotations": {"Species": "9606", "Subgraph": "GABA subgraph"}, "source": 46, "target": 8, "key": 1}, {"relation": "association", "evidence": "1-(3-chlorophenyl)piperazine affects the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein co-treated with GABBR2 protein co-treated with GABRG2 protein]]", "citation": {"type": "PubMed", "name": "Reference from AD_HBP Data", "reference": "21729720"}, "annotations": {"Species": "9606", "Subgraph": "GABA subgraph"}, "source": 46, "target": 18, "key": 0}, {"relation": "increases", "evidence": "In this work, we describe a novel non-coding (nc) RNA (named 17A) RNA polymerase (pol) III-dependent embedded in the human G-protein-coupled receptor 51 gene (GPR51, GABA B2 receptor). The stable expression of 17A in SHSY5Y neuroblastoma cells induces the synthesis of an alternative splicing isoform that abolish GABA B2 intracellular signaling (i.e., inhibition of cAMP accumulation and activation of K(+) channels). Indeed, 17A is expressed in human brain, and we report that it is upregulated in cerebral tissues derived from Alzheimer disease patients. We demonstrate that 17A expression in neuroblastoma cells enhances the secretion of amyloid β peptide (Aβ) and the Aβ x-42/Î‘β x-40 peptide ratio and that its synthesis is induced in response to inflammatory stimuli.", "citation": {"type": "PubMed", "name": "Neurobiol Dis. 2011 Feb;41(2):308-17. doi: 10.1016/j.nbd.2010.09.019. Epub 2010 Oct 1.", "reference": "20888417"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 47, "target": 48, "key": 0}, {"relation": "increases", "evidence": "Nefiracetam is undergoing preclinical and clinical tests as a cognition-enhancing drug in Alzheimer's disease (AD).", "citation": {"type": "PubMed", "name": "Psychopharmacology (Berl). 1997 May;131(2):130-9", "reference": "9201800"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 49, "target": 28, "key": 0}, {"relation": "increases", "evidence": "The nootropic compound nefiracetam was evaluated in 88 older rabbits in a 750-ms delay paradigm of eyeblink classical conditioning (EBCC). Nefiracetam facilitated acquisition of EBCC in older rabbits. EBCC is performed poorly by older humans and is seriously impaired in Alzheimer's disease. These preclinical data in an animal model with clear parallels in humans suggest that nefiracetam may prove effective as a cognition enhancer in clinical trials.", "citation": {"type": "PubMed", "name": "Psychopharmacology (Berl). 1994 Mar;114(2):200-8", "reference": "7838908"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 49, "target": 28, "key": 2}, {"relation": "increases", "evidence": "The results of the present study, thus, suggest that nefiracetam enhances activity of nicotinic ACh receptors by interacting with a PKC pathway, thereby increasing glutamate release from presynaptic terminals, and then leading to a sustained facilitation of hippocampal neurotransmission. This may represent a cellular mechanism underlying the cognition-enhancing action of nefiracetam. The results also provide the possibility that nefiracetam could be developed as a promising therapeutic drug for senile dementia or Alzheimer's disease.", "citation": {"type": "PubMed", "name": "Brain Res Mol Brain Res. 2000 Aug 14;80(1):53-62", "reference": "11039729"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 49, "target": 28, "key": 4}, {"relation": "increases", "evidence": "We have previously demonstrated that the nootropic drug nefiracetam potentiates the activity of both nicotinic acetylcholine and NMDA receptors and that nefiracetam modulates the glycine binding site of the NMDA receptor.", "citation": {"type": "PubMed", "name": "Mol Pharmacol. 2007 Feb;71(2):580-7", "reference": "17095583"}, "object": {"modifier": "Activity"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 49, "target": 27, "key": 0}, {"relation": "increases", "evidence": "In conclusion, nefiracetam enhances NMDA-receptor function through stimulation of its glycine binding site and nefiracetam-induced CaMKII activation likely contributes to improvement of cognition, learning, and memory.", "citation": {"type": "PubMed", "name": "J Pharmacol Sci. 2011;117(1):6-11", "reference": "21821968"}, "object": {"modifier": "Activity"}, "annotations": {"Species": "10116", "Subgraph": "GABA subgraph"}, "source": 49, "target": 27, "key": 2}, {"relation": "increases", "evidence": "We have previously demonstrated that the nootropic drug nefiracetam potentiates the activity of both nicotinic acetylcholine and NMDA receptors and that nefiracetam modulates the glycine binding site of the NMDA receptor.", "citation": {"type": "PubMed", "name": "Mol Pharmacol. 2007 Feb;71(2):580-7", "reference": "17095583"}, "object": {"modifier": "Activity"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 49, "target": 36, "key": 0}, {"relation": "increases", "evidence": "We have previously demonstrated that the nootropic drug nefiracetam potentiates the activity of both nicotinic acetylcholine and NMDA receptors and that nefiracetam modulates the glycine binding site of the NMDA receptor.", "citation": {"type": "PubMed", "name": "Mol Pharmacol. 2007 Feb;71(2):580-7", "reference": "17095583"}, "object": {"modifier": "Activity"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 49, "target": 37, "key": 0}, {"relation": "increases", "evidence": "We have previously demonstrated that the nootropic drug nefiracetam potentiates the activity of both nicotinic acetylcholine and NMDA receptors and that nefiracetam modulates the glycine binding site of the NMDA receptor.", "citation": {"type": "PubMed", "name": "Mol Pharmacol. 2007 Feb;71(2):580-7", "reference": "17095583"}, "object": {"modifier": "Activity"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 49, "target": 31, "key": 0}, {"relation": "increases", "evidence": "We have previously demonstrated that the nootropic drug nefiracetam potentiates the activity of both nicotinic acetylcholine and NMDA receptors and that nefiracetam modulates the glycine binding site of the NMDA receptor.", "citation": {"type": "PubMed", "name": "Mol Pharmacol. 2007 Feb;71(2):580-7", "reference": "17095583"}, "object": {"modifier": "Activity"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 49, "target": 38, "key": 0}, {"relation": "increases", "evidence": "We have previously demonstrated that the nootropic drug nefiracetam potentiates the activity of both nicotinic acetylcholine and NMDA receptors and that nefiracetam modulates the glycine binding site of the NMDA receptor.", "citation": {"type": "PubMed", "name": "Mol Pharmacol. 2007 Feb;71(2):580-7", "reference": "17095583"}, "object": {"modifier": "Activity"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 49, "target": 39, "key": 0}, {"relation": "increases", "evidence": "We have previously demonstrated that the nootropic drug nefiracetam potentiates the activity of both nicotinic acetylcholine and NMDA receptors and that nefiracetam modulates the glycine binding site of the NMDA receptor.", "citation": {"type": "PubMed", "name": "Mol Pharmacol. 2007 Feb;71(2):580-7", "reference": "17095583"}, "object": {"modifier": "Activity"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 49, "target": 40, "key": 0}, {"relation": "increases", "evidence": "We have previously demonstrated that the nootropic drug nefiracetam potentiates the activity of both nicotinic acetylcholine and NMDA receptors and that nefiracetam modulates the glycine binding site of the NMDA receptor.", "citation": {"type": "PubMed", "name": "Mol Pharmacol. 2007 Feb;71(2):580-7", "reference": "17095583"}, "object": {"modifier": "Activity"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 49, "target": 41, "key": 0}, {"relation": "increases", "evidence": "We have previously demonstrated that the nootropic drug nefiracetam potentiates the activity of both nicotinic acetylcholine and NMDA receptors and that nefiracetam modulates the glycine binding site of the NMDA receptor.", "citation": {"type": "PubMed", "name": "Mol Pharmacol. 2007 Feb;71(2):580-7", "reference": "17095583"}, "object": {"modifier": "Activity"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 49, "target": 42, "key": 0}, {"relation": "increases", "evidence": "We have previously demonstrated that the nootropic drug nefiracetam potentiates the activity of both nicotinic acetylcholine and NMDA receptors and that nefiracetam modulates the glycine binding site of the NMDA receptor.", "citation": {"type": "PubMed", "name": "Mol Pharmacol. 2007 Feb;71(2):580-7", "reference": "17095583"}, "object": {"modifier": "Activity"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 49, "target": 34, "key": 0}, {"relation": "increases", "evidence": "We have previously demonstrated that the nootropic drug nefiracetam potentiates the activity of both nicotinic acetylcholine and NMDA receptors and that nefiracetam modulates the glycine binding site of the NMDA receptor.", "citation": {"type": "PubMed", "name": "Mol Pharmacol. 2007 Feb;71(2):580-7", "reference": "17095583"}, "object": {"modifier": "Activity"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 49, "target": 43, "key": 0}, {"relation": "increases", "evidence": "In immunoblotting analysis, nefiracetam treatment increased the PKCalpha activity with a bell-shaped dose-response relationship peaking at 10 nM, thereby increasing phosphorylation of PKC substrate and NMDA receptor. Nefiracetam treatment did not affect the PKA activity.", "citation": {"type": "PubMed", "name": "Mol Pharmacol. 2007 Feb;71(2):580-7", "reference": "17095583"}, "object": {"modifier": "Activity"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 49, "target": 50, "key": 0}, {"relation": "causesNoChange", "evidence": "In immunoblotting analysis, nefiracetam treatment increased the PKCalpha activity with a bell-shaped dose-response relationship peaking at 10 nM, thereby increasing phosphorylation of PKC substrate and NMDA receptor. Nefiracetam treatment did not affect the PKA activity.", "citation": {"type": "PubMed", "name": "Mol Pharmacol. 2007 Feb;71(2):580-7", "reference": "17095583"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 49, "target": 51, "key": 0}, {"relation": "isA", "evidence": "The nefiracetam-induced increase in the frequency of mEPSCs and mIPSCs over and above the level achieved by ACh alone would contribute to the therapeutic effect of nefiracetam as the cholinergic system is known to be downregulated in the brain of Alzheimer's disease patients.The therapeutic effects of galantamine are ascribed to the modest potentiation of nACh receptor and NMDA receptor activities in addition to the modest inhibition of acetylcholinesterase.", "citation": {"type": "PubMed", "name": "Neuroscience. 2009 May 5;160(2):484-91", "reference": "19272425"}, "annotations": {"Species": "10090", "Subgraph": "GABA subgraph"}, "source": 49, "target": 52, "key": 0}, {"relation": "increases", "evidence": "Nefiracetam treatment significantly enhanced long-term potentiation (LTP) with the same bell-shaped dose-response curve. Furthermore, nefiracetam-induced LTP enhancement was closely associated with calcium/calmodulin-dependent protein kinase II (CaMKII) activation with increase in phosphorylation of AMPA-type glutamate receptor subunit 1 (GluA1) (Ser-831) as a postsynaptic CaMKII substrate. ", "citation": {"type": "PubMed", "name": "J Pharmacol Sci. 2011;117(1):6-11", "reference": "21821968"}, "annotations": {"Species": "10116", "Subgraph": "GABA subgraph"}, "source": 49, "target": 53, "key": 0}, {"relation": "increases", "evidence": "Nefiracetam treatment significantly enhanced long-term potentiation (LTP) with the same bell-shaped dose-response curve. Furthermore, nefiracetam-induced LTP enhancement was closely associated with calcium/calmodulin-dependent protein kinase II (CaMKII) activation with increase in phosphorylation of AMPA-type glutamate receptor subunit 1 (GluA1) (Ser-831) as a postsynaptic CaMKII substrate. ", "citation": {"type": "PubMed", "name": "J Pharmacol Sci. 2011;117(1):6-11", "reference": "21821968"}, "object": {"modifier": "Activity"}, "annotations": {"Species": "10116", "Subgraph": "GABA subgraph"}, "source": 49, "target": 54, "key": 0}, {"relation": "increases", "evidence": "In conclusion, nefiracetam enhances NMDA-receptor function through stimulation of its glycine binding site and nefiracetam-induced CaMKII activation likely contributes to improvement of cognition, learning, and memory.", "citation": {"type": "PubMed", "name": "J Pharmacol Sci. 2011;117(1):6-11", "reference": "21821968"}, "object": {"modifier": "Activity"}, "annotations": {"Species": "10116", "Subgraph": "GABA subgraph"}, "source": 49, "target": 54, "key": 1}, {"relation": "increases", "evidence": "The results of the present study, thus, suggest that nefiracetam enhances activity of nicotinic ACh receptors by interacting with a PKC pathway, thereby increasing glutamate release from presynaptic terminals, and then leading to a sustained facilitation of hippocampal neurotransmission. This may represent a cellular mechanism underlying the cognition-enhancing action of nefiracetam. The results also provide the possibility that nefiracetam could be developed as a promising therapeutic drug for senile dementia or Alzheimer's disease.", "citation": {"type": "PubMed", "name": "Brain Res Mol Brain Res. 2000 Aug 14;80(1):53-62", "reference": "11039729"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 49, "target": 55, "key": 0}, {"relation": "increases", "evidence": "Nefiracetam treatment significantly enhanced long-term potentiation (LTP) with the same bell-shaped dose-response curve. Furthermore, nefiracetam-induced LTP enhancement was closely associated with calcium/calmodulin-dependent protein kinase II (CaMKII) activation with increase in phosphorylation of AMPA-type glutamate receptor subunit 1 (GluA1) (Ser-831) as a postsynaptic CaMKII substrate. ", "citation": {"type": "PubMed", "name": "J Pharmacol Sci. 2011;117(1):6-11", "reference": "21821968"}, "annotations": {"Species": "10116", "Subgraph": "GABA subgraph"}, "source": 54, "target": 56, "key": 0}, {"relation": "increases", "evidence": "The results of the present study, thus, suggest that nefiracetam enhances activity of nicotinic ACh receptors by interacting with a PKC pathway, thereby increasing glutamate release from presynaptic terminals, and then leading to a sustained facilitation of hippocampal neurotransmission. This may represent a cellular mechanism underlying the cognition-enhancing action of nefiracetam. The results also provide the possibility that nefiracetam could be developed as a promising therapeutic drug for senile dementia or Alzheimer's disease.", "citation": {"type": "PubMed", "name": "Brain Res Mol Brain Res. 2000 Aug 14;80(1):53-62", "reference": "11039729"}, "object": {"modifier": "Activity"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 55, "target": 36, "key": 0}, {"relation": "increases", "evidence": "The results of the present study, thus, suggest that nefiracetam enhances activity of nicotinic ACh receptors by interacting with a PKC pathway, thereby increasing glutamate release from presynaptic terminals, and then leading to a sustained facilitation of hippocampal neurotransmission. This may represent a cellular mechanism underlying the cognition-enhancing action of nefiracetam. The results also provide the possibility that nefiracetam could be developed as a promising therapeutic drug for senile dementia or Alzheimer's disease.", "citation": {"type": "PubMed", "name": "Brain Res Mol Brain Res. 2000 Aug 14;80(1):53-62", "reference": "11039729"}, "object": {"modifier": "Activity"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 55, "target": 37, "key": 0}, {"relation": "increases", "evidence": "The results of the present study, thus, suggest that nefiracetam enhances activity of nicotinic ACh receptors by interacting with a PKC pathway, thereby increasing glutamate release from presynaptic terminals, and then leading to a sustained facilitation of hippocampal neurotransmission. This may represent a cellular mechanism underlying the cognition-enhancing action of nefiracetam. The results also provide the possibility that nefiracetam could be developed as a promising therapeutic drug for senile dementia or Alzheimer's disease.", "citation": {"type": "PubMed", "name": "Brain Res Mol Brain Res. 2000 Aug 14;80(1):53-62", "reference": "11039729"}, "object": {"modifier": "Activity"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 55, "target": 31, "key": 0}, {"relation": "increases", "evidence": "The results of the present study, thus, suggest that nefiracetam enhances activity of nicotinic ACh receptors by interacting with a PKC pathway, thereby increasing glutamate release from presynaptic terminals, and then leading to a sustained facilitation of hippocampal neurotransmission. This may represent a cellular mechanism underlying the cognition-enhancing action of nefiracetam. The results also provide the possibility that nefiracetam could be developed as a promising therapeutic drug for senile dementia or Alzheimer's disease.", "citation": {"type": "PubMed", "name": "Brain Res Mol Brain Res. 2000 Aug 14;80(1):53-62", "reference": "11039729"}, "object": {"modifier": "Activity"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 55, "target": 38, "key": 0}, {"relation": "increases", "evidence": "The results of the present study, thus, suggest that nefiracetam enhances activity of nicotinic ACh receptors by interacting with a PKC pathway, thereby increasing glutamate release from presynaptic terminals, and then leading to a sustained facilitation of hippocampal neurotransmission. This may represent a cellular mechanism underlying the cognition-enhancing action of nefiracetam. The results also provide the possibility that nefiracetam could be developed as a promising therapeutic drug for senile dementia or Alzheimer's disease.", "citation": {"type": "PubMed", "name": "Brain Res Mol Brain Res. 2000 Aug 14;80(1):53-62", "reference": "11039729"}, "object": {"modifier": "Activity"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 55, "target": 39, "key": 0}, {"relation": "increases", "evidence": "The results of the present study, thus, suggest that nefiracetam enhances activity of nicotinic ACh receptors by interacting with a PKC pathway, thereby increasing glutamate release from presynaptic terminals, and then leading to a sustained facilitation of hippocampal neurotransmission. This may represent a cellular mechanism underlying the cognition-enhancing action of nefiracetam. The results also provide the possibility that nefiracetam could be developed as a promising therapeutic drug for senile dementia or Alzheimer's disease.", "citation": {"type": "PubMed", "name": "Brain Res Mol Brain Res. 2000 Aug 14;80(1):53-62", "reference": "11039729"}, "object": {"modifier": "Activity"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 55, "target": 40, "key": 0}, {"relation": "increases", "evidence": "The results of the present study, thus, suggest that nefiracetam enhances activity of nicotinic ACh receptors by interacting with a PKC pathway, thereby increasing glutamate release from presynaptic terminals, and then leading to a sustained facilitation of hippocampal neurotransmission. This may represent a cellular mechanism underlying the cognition-enhancing action of nefiracetam. The results also provide the possibility that nefiracetam could be developed as a promising therapeutic drug for senile dementia or Alzheimer's disease.", "citation": {"type": "PubMed", "name": "Brain Res Mol Brain Res. 2000 Aug 14;80(1):53-62", "reference": "11039729"}, "object": {"modifier": "Activity"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 55, "target": 41, "key": 0}, {"relation": "increases", "evidence": "The results of the present study, thus, suggest that nefiracetam enhances activity of nicotinic ACh receptors by interacting with a PKC pathway, thereby increasing glutamate release from presynaptic terminals, and then leading to a sustained facilitation of hippocampal neurotransmission. This may represent a cellular mechanism underlying the cognition-enhancing action of nefiracetam. The results also provide the possibility that nefiracetam could be developed as a promising therapeutic drug for senile dementia or Alzheimer's disease.", "citation": {"type": "PubMed", "name": "Brain Res Mol Brain Res. 2000 Aug 14;80(1):53-62", "reference": "11039729"}, "object": {"modifier": "Activity"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 55, "target": 42, "key": 0}, {"relation": "increases", "evidence": "The results of the present study, thus, suggest that nefiracetam enhances activity of nicotinic ACh receptors by interacting with a PKC pathway, thereby increasing glutamate release from presynaptic terminals, and then leading to a sustained facilitation of hippocampal neurotransmission. This may represent a cellular mechanism underlying the cognition-enhancing action of nefiracetam. The results also provide the possibility that nefiracetam could be developed as a promising therapeutic drug for senile dementia or Alzheimer's disease.", "citation": {"type": "PubMed", "name": "Brain Res Mol Brain Res. 2000 Aug 14;80(1):53-62", "reference": "11039729"}, "object": {"modifier": "Activity"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 55, "target": 34, "key": 0}, {"relation": "increases", "evidence": "The results of the present study, thus, suggest that nefiracetam enhances activity of nicotinic ACh receptors by interacting with a PKC pathway, thereby increasing glutamate release from presynaptic terminals, and then leading to a sustained facilitation of hippocampal neurotransmission. This may represent a cellular mechanism underlying the cognition-enhancing action of nefiracetam. The results also provide the possibility that nefiracetam could be developed as a promising therapeutic drug for senile dementia or Alzheimer's disease.", "citation": {"type": "PubMed", "name": "Brain Res Mol Brain Res. 2000 Aug 14;80(1):53-62", "reference": "11039729"}, "object": {"modifier": "Activity"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 55, "target": 43, "key": 0}, {"relation": "increases", "evidence": "The results of the present study, thus, suggest that nefiracetam enhances activity of nicotinic ACh receptors by interacting with a PKC pathway, thereby increasing glutamate release from presynaptic terminals, and then leading to a sustained facilitation of hippocampal neurotransmission. This may represent a cellular mechanism underlying the cognition-enhancing action of nefiracetam. The results also provide the possibility that nefiracetam could be developed as a promising therapeutic drug for senile dementia or Alzheimer's disease.", "citation": {"type": "PubMed", "name": "Brain Res Mol Brain Res. 2000 Aug 14;80(1):53-62", "reference": "11039729"}, "object": {"modifier": "Activity"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 55, "target": 44, "key": 0}, {"relation": "association", "evidence": "In addition, zif268 alters the transcription of genes associated with GABA(A)R expression and trafficking, such as ubiquilin and gephyrin.", "citation": {"type": "PubMed", "name": "Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7", "reference": "19909279"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 57, "target": 3, "key": 0}, {"relation": "association", "evidence": "Further, EGR1 levels were negatively correlated with hippocampal amyloid-β plaque burden.This study presents global gene expression profiles associated with GA immunization in a glaucoma rat model.", "citation": {"type": "PubMed", "name": "Invest Ophthalmol Vis Sci. 2011 Nov 21;52(12):9033-46", "reference": "21969301"}, "annotations": {"Species": "10116", "MeSHDisease": "Glaucoma", "NervousSystem": "Hippocampus", "Subgraph": "GABA subgraph"}, "source": 58, "target": 3, "key": 0}, {"relation": "increases", "evidence": "In AD-Tg mice, a significant increase in hippocampal EGR1 protein levels was also found in response to GA immunization.", "citation": {"type": "PubMed", "name": "Invest Ophthalmol Vis Sci. 2011 Nov 21;52(12):9033-46", "reference": "21969301"}, "annotations": {"MeSHDisease": "Alzheimer Disease", "NervousSystem": "Hippocampus", "Species": "10090", "Subgraph": "GABA subgraph"}, "source": 59, "target": 3, "key": 0}, {"relation": "increases", "evidence": "We show that Egr-1 binds to PSEN-P2, and that PSEN-P2 activity is increased threefold by overexpression of Egr-1, and by 12-O-tetradecanoylphorbol-13-acetate (TPA), which induces physiological Egr-1 levels.", "citation": {"type": "PubMed", "name": "Gene. 2003 Oct 30;318:113-24", "reference": "14585504"}, "object": {"modifier": "Activity"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 60, "target": 6, "key": 1}, {"relation": "increases", "evidence": "Copper Sulfate results in increased expression of GABRA5 mRNA", "citation": {"type": "PubMed", "name": "Reference from AD_HBP Data", "reference": "19549813"}, "annotations": {"Species": "9606", "Subgraph": "GABA subgraph"}, "source": 61, "target": 62, "key": 0}, {"relation": "decreases", "evidence": "Copper Sulfate results in decreased expression of GABRB3 mRNA", "citation": {"type": "PubMed", "name": "Reference from AD_HBP Data", "reference": "19549813"}, "annotations": {"Species": "9606", "Subgraph": "GABA subgraph"}, "source": 61, "target": 63, "key": 0}, {"relation": "association", "evidence": "Estradiol affects the expression of GABRA4 mRNA", "citation": {"type": "PubMed", "name": "Reference from AD_HBP Data", "reference": "16000229"}, "annotations": {"Species": "9606", "Subgraph": "GABA subgraph"}, "source": 64, "target": 65, "key": 0}, {"relation": "increases", "evidence": "Estradiol results in increased expression of GABRA3 mRNA", "citation": {"type": "PubMed", "name": "Reference from AD_HBP Data", "reference": "16000229"}, "annotations": {"Subgraph": "GABA subgraph"}, "source": 64, "target": 66, "key": 0}, {"relation": "association", "evidence": "Estradiol affects the expression of GABRA4 mRNA", "citation": {"type": "PubMed", "name": "Reference from AD_HBP Data", "reference": "16000229"}, "annotations": {"Species": "9606", "Subgraph": "GABA subgraph"}, "source": 65, "target": 64, "key": 0}]};
    </script>
    <script src="https://npmcdn.com/tether@1.2.4/dist/js/tether.min.js"></script>
    <script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.1.1/jquery.min.js"></script>
    <script type="text/javascript"
            src="https://cdnjs.cloudflare.com/ajax/libs/jqueryui/1.12.1/jquery-ui.min.js"></script>
    <script type="text/javascript"
            src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/4.0.0-alpha.6/js/bootstrap.min.js"></script>
    <script type="text/javascript"
            src="https://cdnjs.cloudflare.com/ajax/libs/d3/4.5.0/d3.min.js"></script>
    <script type="text/javascript"
            src="https://cdnjs.cloudflare.com/ajax/libs/jquery-validate/1.16.0/jquery.validate.min.js"></script>
    <script type="text/javascript"
            src="https://cdnjs.cloudflare.com/ajax/libs/svg.js/2.4.0/svg.min.js"></script>
    <script type="text/javascript"
            src="https://cdnjs.cloudflare.com/ajax/libs/FileSaver.js/1.3.3/FileSaver.min.js"></script>
    <script type="text/javascript">
        // Initialize d3.js force to plot the networks from neo4j json
        function init_d3_force(graph) {

            //////////////////////////////
            // Main graph visualization //
            //////////////////////////////

            d = document;
            e = d.documentElement;
            g = d.getElementsByTagName('body')[0];


            // Graph uses 0.85 x 0.85 of the window size
            var w = $("#graph-chart").width(), h = w.innerHeight ||
                e.clientHeight || g.clientHeight;

            var focus_node = null, highlight_node = null;

            // Highlight color of the nodes
            var highlight_color = "#4EB2D4";

            // Size when zooming scale
            var size = d3.scalePow().exponent(1)
                .domain([1, 100])
                .range([8, 24]);

            // Simulation parameters
            var linkDistance = 100, fCharge = -1000, linkStrength = 0.7, collideStrength = 1;

            // Simulation defined with variables
            var simulation = d3.forceSimulation()
                .force("link", d3.forceLink()
                    .distance(linkDistance)
                    .strength(linkStrength)
                )
                .force("collide", d3.forceCollide()
                    .radius(function (d) {
                        return d.r + 10
                    })
                    .strength(collideStrength)
                )
                .force("charge", d3.forceManyBody()
                    .strength(fCharge)
                )
                .force("center", d3.forceCenter(w / 2, h / 2))
                .force("y", d3.forceY(0))
                .force("x", d3.forceX(0));

            // Pin down functionality
            var node_drag = d3.drag()
                .on("start", dragstarted)
                .on("drag", dragged)
                .on("end", dragended);

            function dragstarted(d) {
                if (!d3.event.active) simulation.alphaTarget(0.3).restart();
                d.fx = d.x;
                d.fy = d.y;
            }

            function dragged(d) {
                d.fx = d3.event.x;
                d.fy = d3.event.y;
            }

            function dragended(d) {
                if (!d3.event.active) simulation.alphaTarget(0);
            }

            function releasenode(d) {
                d.fx = null;
                d.fy = null;
            }

            //END Pin down functionality

            var color_circunferencia = "black";
            var default_link_color = "#888";
            var nominal_base_node_size = 8;
            // Normal and highlighted stroke of the links (double the width of the link when highlighted)
            var nominal_stroke = 1.5, highlighted_stroke = 3;
            // Zoom variables
            var min_zoom = 0.1, max_zoom = 10;
            var border = 1, bordercolor = 'black';

            var svg = d3.select("#graph-chart").append("svg")
                .attr("width", w)
                .attr("height", h);

            // // Create definition for arrowhead.
            svg.append("defs").append("marker")
                .attr("id", "arrowhead")
                .attr("viewBox", "0 -5 10 10")
                .attr("refX", 20)
                .attr("refY", 0)
                .attr("markerUnits", "strokeWidth")
                .attr("markerWidth", 6)
                .attr("markerHeight", 6)
                .attr("orient", "auto")
                .append("path")
                .attr("d", "M0,-5L10,0L0,5");

            // // Create definition for stub.
            svg.append("defs").append("marker")
                .attr("id", "stub")
                .attr("viewBox", "-1 -5 2 10")
                .attr("refX", 15)
                .attr("refY", 0)
                .attr("markerUnits", "strokeWidth")
                .attr("markerWidth", 6)
                .attr("markerHeight", 6)
                .attr("orient", "auto")
                .append("path")
                .attr("d", "M 0,0 m -1,-5 L 1,-5 L 1,5 L -1,5 Z");

            // Background
            svg.append("rect")
                .attr("width", "100%")
                .attr("height", "100%")
                .attr("fill", "#ffffff")
                .style("pointer-events", "all")
                // Zoom + panning functionality
                .call(d3.zoom()
                    .scaleExtent([min_zoom, max_zoom])
                    .on("zoom", zoomed))
                .on("dblclick.zoom", null);


            function zoomed() {
                g.attr("transform", d3.event.transform);
            }


            // g = svg object where the graph will be appended
            var g = svg.append("g");

            var linkedByIndex = {};
            graph.links.forEach(function (d) {
                linkedByIndex[d.source + "," + d.target] = true;
            });

            function isConnected(a, b) {
                return linkedByIndex[a.index + "," + b.index] || linkedByIndex[b.index + "," + a.index] || a.index == b.index;
            }

            function ticked() {
                link
                    .attr("x1", function (d) {
                        return d.source.x;
                    })
                    .attr("y1", function (d) {
                        return d.source.y;
                    })
                    .attr("x2", function (d) {
                        return d.target.x;
                    })
                    .attr("y2", function (d) {
                        return d.target.y;
                    });

                node
                    .attr("transform", function (d) {
                        return "translate(" + d.x + ", " + d.y + ")";
                    });
            }


            simulation
                .nodes(graph.nodes)
                .on("tick", ticked);

            simulation.force("link")
                .links(graph.links);

            // Definition of links nodes text...

            var link = g.selectAll(".link")
                .data(graph.links)
                .enter().append("line")
                .style("stroke-width", nominal_stroke)
                .style("stroke", default_link_color)
                .attr("class", function (d) {
                    if (['decreases', 'directlyDecreases', 'increases', 'directlyIncreases', 'negativeCorrelation',
                            'positiveCorrelation'].indexOf(d.relation) >= 0) {
                        return "link link_continuous"
                    }
                    else {
                        return "link link_dashed"
                    }
                })
                .attr("marker-start", function (d) {
                    if ('positiveCorrelation' == d.relation) {
                        return "url(#arrowhead)"
                    }
                    else if ('negativeCorrelation' == d.relation) {
                        return "url(#stub)"
                    }
                    else {
                        return ""
                    }
                })
                .attr("marker-end", function (d) {
                    if (['increases', 'directlyIncreases', 'positiveCorrelation'].indexOf(d.relation) >= 0) {
                        return "url(#arrowhead)"
                    }
                    else if (['decreases', 'directlyDecreases', 'negativeCorrelation'].indexOf(d.relation) >= 0) {
                        return "url(#stub)"
                    }
                    else {
                        return ""
                    }
                });

            var node = g.selectAll(".nodes")
                .data(graph.nodes)
                .enter().append("g")
                .attr("class", "node")
                // Next two lines -> Pin down functionality
                .on('dblclick', releasenode)
                .call(node_drag);

            var circle = node.append("path")
                .attr("d", d3.symbol()
                    .size(function (d) {
                        return Math.PI * Math.pow(size(d.size) || nominal_base_node_size, 2);
                    })
                )
                .attr("class", function (d) {
                    return d.function
                })
                .style("stroke-width", nominal_stroke)
                .style("stroke", color_circunferencia);

            var text = node.append("text")
                .attr("class", "node-name")
                // .attr("id", nodehashes[d])
                .attr("fill", "black")
                .attr("dx", 12)
                .attr("dy", ".35em")
                .text(function (d) {
                    return d.name
                });

            // Highlight on mouseenter and back to normal on mouseout
            node.on("mouseenter", function (d) {
                set_highlight(d);
            })
                .on("mousedown", function () {
                    d3.event.stopPropagation();
                }).on("mouseout", function () {
                exit_highlight();
            });

            function exit_highlight() {
                highlight_node = null;
                if (focus_node === null) {
                    if (highlight_color != color_circunferencia) {
                        circle.style("stroke", color_circunferencia);
                        text.style("font-weight", "normal");
                        link.style("stroke-width", nominal_stroke);
                    }
                }
            }

            function set_highlight(d) {
                if (focus_node !== null) d = focus_node;
                highlight_node = d;

                if (highlight_color != color_circunferencia) {
                    circle.style("stroke", function (o) {
                        return isConnected(d, o) ? highlight_color : color_circunferencia;
                    });
                    text.style("font-weight", function (o) {
                        return isConnected(d, o) ? "bold" : "normal";
                    });
                    link.style("stroke-width", function (o) {
                        return o.source.index == d.index || o.target.index == d.index ? highlighted_stroke : nominal_stroke;
                    });
                }
            }

            // Freeze the graph when space is pressed
            function freezeGraph() {
                // Space button Triggers STOP
                if (d3.event.keyCode == 32) {
                    simulation.stop();
                }
            }

            // Search functionality to check if array exists in an array of arrays
            function searchForArray(haystack, needle) {
                var i, j, current;
                for (i = 0; i < haystack.length; ++i) {
                    if (needle.length === haystack[i].length) {
                        current = haystack[i];
                        for (j = 0; j < needle.length && needle[j] === current[j]; ++j);
                        if (j === needle.length)
                            return i;
                    }
                }
                return -1;
            }

            function reset_attributes_on_double_click() {

                // On double click reset attributes (Important disabling the zoom behavior of dbl click because it interferes with this)
                svg.on("dblclick", function () {
                    // SET default color
                    svg.selectAll(".link").style("stroke", default_link_color);
                    // SET default attributes //
                    svg.selectAll(".link, .node").style("visibility", "visible")
                        .style("opacity", "1");
                    // Show node names
                    svg.selectAll(".node-name").style("visibility", "visible").style("opacity", "1");
                });

            }

            function reset_attributes() {
                // Reset visibility and opacity
                svg.selectAll(".link, .node").style("visibility", "visible").style("opacity", "1");
                // Show node names
                svg.selectAll(".node-name").style("visibility", "visible").style("opacity", "1");
            }

            function hide_select_nodes_text(node_list, visualization) {
                // Filter the text to those not belonging to the list of node names

                var not_selected_names = g.selectAll(".node-name").filter(function (d) {
                    return node_list.indexOf(d.name) < 0;
                });

                if (visualization != true) {
                    //noinspection JSDuplicatedDeclaration
                    var visualization_option = "opacity", on = "1", off = "0.1";
                } else {
                    //noinspection JSDuplicatedDeclaration
                    var visualization_option = "visibility", on = "visible", off = "hidden";
                }

                // Change display property to 'none'
                $.each(not_selected_names._groups[0], function (index, value) {
                    value.style.setProperty(visualization_option, off);
                });
            }

            function hide_select_nodes_text_paths(data, visualization) {

                // Array with all nodes in all paths
                var nodes_in_paths = [];

                $.each(data, function (index, value) {
                    $.each(value, function (index, value) {
                        nodes_in_paths.push(value);
                    });
                });

                // Filter the text whose innerHTML is not belonging to the list of nodeIDs
                var not_selected_names = g.selectAll(".node-name").filter(function (d) {
                    return nodes_in_paths.indexOf(d.id) < 0;
                });

                if (visualization != true) {
                    //noinspection JSDuplicatedDeclaration
                    var visualization_option = "opacity", on = "1", off = "0.1";
                } else {
                    //noinspection JSDuplicatedDeclaration
                    var visualization_option = "visibility", on = "visible", off = "hidden";
                }

                // Change display property to 'none'
                $.each(not_selected_names._groups[0], function (index, value) {
                    value.style.setProperty(visualization_option, off);
                });
            }

            function selected_edge_highlight(edge) {

                // Array with names of the nodes in the selected edge
                var mapped_nodes_names = [];

                // Filtered not selected links
                var links_not_mapped = g.selectAll(".link").filter(function (el) {

                    if (el.label == edge) {
                        mapped_nodes_names.push(el.source.id);
                        mapped_nodes_names.push(el.target.id);
                    }

                    // Source and target should be present in the edge
                    return el.label != edge;
                });

                hide_select_nodes_text(mapped_nodes_names, false);

                var not_mapped_nodes_objects = node.filter(function (el) {
                    return mapped_nodes_names.indexOf(el.id) < 0;
                });

                not_mapped_nodes_objects.style("opacity", "0.1");
                links_not_mapped.style("opacity", "0.1");

            }

            // Highlight nodes from array of ids and change the opacity of the rest of nodes
            function selected_nodes_highlight(node_list) {

                hide_select_nodes_text(node_list, false);
                console.log('Node list');
                console.log(node_list);

                // Filter not mapped nodes to change opacity
                var not_mapped_nodes_objects = svg.selectAll(".node").filter(function (el) {
                    return searchForArray(node_list, el.id) < 0;
                });

                // Not mapped links
                var links_not_mapped = g.selectAll(".link").filter(function (el) {
                    // Source and target should be present in the edge

                    return !((searchForArray(node_list, el.source.id) >= 0 || searchForArray(node_list, el.target.id) >= 0));
                });

                not_mapped_nodes_objects.style("opacity", "0.1");
                links_not_mapped.style("opacity", "0.1");
            }

            function color_all_paths(data, visualization) {

                /**
                 * Returns a random integer between min (inclusive) and max (inclusive)
                 * Using Math.round() will give you a non-uniform distribution!
                 */
                function getRandomInt(min, max) {
                    return Math.floor(Math.random() * (max - min + 1)) + min;
                }

                // data: nested array with all nodes in each path
                // visualization: parameter with visualization info ('hide' || 'opaque)

                var link = g.selectAll(".link");

                ///////// Filter the nodes ////////

                // Array with all nodes in all paths
                var nodes_in_paths = [];

                $.each(data, function (index, value) {
                    $.each(value, function (index, value) {
                        nodes_in_paths.push(value);
                    });
                });

                // Filtering the nodes that are not in any of the paths
                var not_mapped_nodes_objects = svg.selectAll(".node").filter(function (el) {
                    return nodes_in_paths.indexOf(el.id) < 0;
                });

                if (visualization != true) {
                    //noinspection JSDuplicatedDeclaration
                    var visualization_option = "opacity", on = "1", off = "0.1";
                } else {
                    //noinspection JSDuplicatedDeclaration
                    var visualization_option = "visibility", on = "visible", off = "hidden";
                }
                not_mapped_nodes_objects.style(visualization_option, off);

                ///////// Colour links in each path differently and hide others ////////

                // Colour the links ( Max 21 paths )
                var color_list = ['#ff2200', ' #282040', ' #a68d7c', ' #332b1a', ' #435916', ' #00add9', ' #bfd0ff', ' #f200c2',
                    ' #990014', ' #d97b6c', ' #ff8800', ' #f2ffbf', ' #e5c339', ' #5ba629', ' #005947', ' #005580', ' #090040',
                    ' #8d36d9', ' #e5005c', ' #733941', ' #993d00', ' #80ffb2', ' #66421a', ' #e2f200', ' #20f200', ' #80fff6',
                    ' #002b40', ' #6e698c', ' #802079', ' #330014', ' #331400', ' #ffc480', ' #7ca682', ' #264a4d', ' #0074d9',
                    ' #220080', ' #d9a3d5', ' #f279aa'];

                // iter = number of paths ( Max 21 paths )
                if (data.length > color_list.length) {
                    //noinspection JSDuplicatedDeclaration
                    var iter = color_list.length;
                } else {
                    //noinspection JSDuplicatedDeclaration
                    var iter = data.length;
                }

                // First hide or set to opacity 0.1 all links
                link.style(visualization_option, off);

                // Make visible again all the edges that are in any of the paths
                var links_in_paths = [];

                for (var x = 0; x < iter; x++) {

                    // Push the array (each path) to a new one where all paths are stored
                    var path = link.filter(function (el) {
                        // Source and target should be present in the edge and the distance in the array should be one
                        return ((data[x].indexOf(el.source.id) >= 0 && data[x].indexOf(el.target.id) >= 0)
                        && (Math.abs(data[x].indexOf(el.source.id) - data[x].indexOf(el.target.id)) == 1));
                    });

                    links_in_paths.push(path);
                }

                // Only the links that are in any of the paths are visible
                for (var j = 0, len = links_in_paths.length; j < len; j++) {
                    links_in_paths[j].style(visualization_option, on);
                }

                // For each path give a different color
                for (var i = 0; i < iter; i++) {
                    var links_in_this_path = link.filter(function (el) {
                        // Source and target should be present in the edge and the distance in the array should be one
                        return ((data[i].indexOf(el.source.id) >= 0 && data[i].indexOf(el.target.id) >= 0)
                        && (Math.abs(data[i].indexOf(el.source.id) - data[i].indexOf(el.target.id)) == 1));
                    });

                    // Select randomly a color and apply to this path
                    links_in_this_path.style("stroke", color_list[getRandomInt(0, 21)]);
                }

            }

            // Call freezeGraph when a key is pressed, freezeGraph checks whether this key is "Space" that triggers the freeze
            d3.select(window).on("keydown", freezeGraph);

            /////////////////////////
            // Additional features //
            /////////////////////////

            function download_link(response, name) {
                var element = document.createElement('a');
                element.setAttribute('href', 'data:text/plain;charset=utf-8,' + encodeURIComponent(response));
                element.setAttribute('download', name);
                element.style.display = 'none';
                document.body.appendChild(element);
                element.click();
                document.body.removeChild(element);
            }

            // Build the node multi-level dropdown
            $('#node-list').append("<ul id='node-list-ul' class='dropdown-menu node-dropdown' role='menu' " +
                "aria-labelledby='dropdownMenu' " + "class='no-bullets min-padding-left'></ul>");

            // Variable with all node names for shortest path autocompletion input
            var node_names = [];

            $.each(graph.nodes, function (key, value_array) {

                node_names.push(value_array.id);

                $("#node-list-ul").append("<li class='dropdown-submenu node_selector node-dropdown'><a id='" +
                    value_array.id + "'>" + value_array.name + "<ul class='dropdown-menu no-bullets min-padding-left'>" +
                    "<li>Name: " + value_array.name + "" + "</li><li>Namespace: " + value_array.namespace + "</li>" +
                    "<li>BEL function: " + value_array.function + "</li></ul></li>");
            });

            ///////////////////////////////////////
            // Build the edge multi-level dropdown
            ///////////////////////////////////////

            $('#edge-list').append("<ul id='edge-list-ul' class='dropdown-menu edge-dropdown' role='menu' " +
                "aria-labelledby='dropdownMenu' " + "class='no-bullets min-padding-left'></ul>");

            $.each(graph.links, function (key, value_array) {

                var pubmed_hyperlink = 'https://www.ncbi.nlm.nih.gov/pubmed/' + value_array.citation.reference;

                $("#edge-list-ul").append("<li class='dropdown-submenu edge_selector '><a id='value'>" +
                    value_array.source.name + ' ' + value_array.relation + ' ' + value_array.target.name +
                    "</a><ul class='dropdown-menu no-bullets min-padding-left edge-info'><li><span class='color_red'>" +
                    "From: </span>" + value_array.source.name + "</li><li><span class='color_red'>To: </span>" +
                    value_array.target.name + "</li><li><span class='color_red'>Relationship </span>" + value_array.relation +
                    "</li><li><span class='color_red'>PubMed: </span><a href='" + pubmed_hyperlink + "' target='_blank' " +
                    "style='color: blue; text-decoration: underline'>" + value_array.citation.reference + "</a></li><li>" +
                    "<span class='color_red'>Journal: </span>" + value_array.citation.name + "</li><li>" +
                    "<span class='color_red'>Evidence: </span>" + value_array.SupportingText + "+</li><li>" +
                    "<span class='color_red'>Context: </span>" + value_array.context + "" + "</li></ul></li>");

            });

            // Shortest path autocompletion input
            node_names = node_names.sort();

            $("#source-node").autocomplete({
                source: node_names,
                appendTo: "#info-graph"
            });

            $("#target-node").autocomplete({
                source: node_names,
                appendTo: "#info-graph"
            });

            // Select node in the graph from selector
            $(".node_selector").click(function () {

                reset_attributes();

                // $this=li, first element is the a with the id of the node
                var node_array = [$(this)[0].childNodes[0].id.split(',')];
                selected_nodes_highlight(node_array);
                reset_attributes_on_double_click();

            });

            // Update Node Dropdown
            $("#node-search").on("keyup", function () {
                // Get value from search form (fixing spaces and case insensitive
                var searchText = $(this).val();
                searchText = searchText.toLowerCase();
                searchText = searchText.replace(/\s+/g, '');

                $.each($('#node-list-ul')[0].childNodes, dropdown_update);
                function dropdown_update() {
                    var currentLiText = $(this).find("a")[0].innerHTML,
                        showCurrentLi = ((currentLiText.toLowerCase()).replace(/\s+/g, '')).indexOf(searchText) !== -1;
                    $(this).toggle(showCurrentLi);
                }
            });

            // Update Edge Dropdown
            $("#edge-search").on("keyup", function () {
                // Get value from search form (fixing spaces and case insensitive
                var searchText = $(this).val();
                searchText = searchText.toLowerCase();
                searchText = searchText.replace(/\s+/g, '');

                $.each($('#edge-list-ul')[0].childNodes, dropdown_update);
                function dropdown_update() {

                    var currentLiText = $(this).find("a")[0].innerHTML,
                        showCurrentLi = ((currentLiText.toLowerCase()).replace(/\s+/g, '')).indexOf(searchText) !== -1;
                    $(this).toggle(showCurrentLi);
                }
            });

            // Select node in the graph from selector
            $(".edge_selector").on("click", "#value", function () {
                console.log($(this)[0])

                reset_attributes();

                // textContent or innerHTML
                var edge_name = $(this)[0].innerHTML;
                selected_edge_highlight(edge_name);

                reset_attributes_on_double_click()
            });

            // Hide text in graph
            $("#hide_node_names").on("click", function () {
                svg.selectAll(".node-name").style("display", "none");
            });

            // Hide text in graph
            $("#restore_node_names").on("click", function () {
                svg.selectAll(".node-name").style("display", "block");
            });

            // Hide text in graph
            $("#restore").on("click", function () {
                reset_attributes();
            });
        }
        ;

        // Saves visualized network as image
        $("#save-svg-graph").click(function () {
            var graphName = "graph_image";
            var svgContainer = $("svg").svg(),
                svgGet = svgContainer.svg("get");
            svgGet = svgGet.toSVG();
            var blob = new Blob([svgGet], {type: "data:image/svg+xml;charset="});
            saveAs(blob, graphName + ".svg");
        });


    </script>
    <script type="text/javascript">
        $(document).ready(function () {
            init_d3_force(window.graph);
        });
    </script>

</head>
<body>
<div id="graph-chart">
</div>
</body>
</html>
